Budget Impact Models

Budget Impact Models

The RXA Budget Impact Model enables pharmaceutical companies to use the NHS’s own data to produce realistic and plausible cost saving prescribing switch strategies.

With the RXA Budget Impact model you can:

  • Create summary overviews at annual and portfolio levels
  • Drill down to underlying detailed product-specific calculations
  • Use tables, charts and maps in the purpose-built dashboard to provide extensive, highly visual and easy to interpret analytics
  • Make on the spot adjustments of model parameters – (E.g. switch %) via slider controls
  • Automatically rank the top ‘X’ GP practices to target
  • Create outputs to leave behind after meetings – Including CCG or GP practice level branded reports containing details of identified cost savings
We make analytics simple
Request your demonstration today

“Need to analyse the community market? This tool can do that.”

Senior Manager, Global Healthcare Company, 2016

“Export to Excel is straightforward, which facilitates easy manipulation if required, for example, for territory planning.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“RX Analyser is an extremely intuitive tool with numerous beneficial features.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“We are working in an ever evolving industry where data increasingly drives marketing and sales activity. I believe RX Analyser is the most comprehensive analytics tool available for prescription data analysis. I can already see other business areas (within my company) that could really benefit.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“I am regularly told by my sales team that Inspiremed’s software is one of the best tools in sales, measurement and planning that they’ve ever used.”

National Sales Manager, Leading UK Pharmaceutical Company

“I use the data from RXA Budget Impact Model daily. It is the core of everything we do! I cannot recommend the model more. It has had a substantial impact on our business across the board and I would not be without it.”

Country Manager UK, Leading Diagnostics Company

Sign up for added insights